Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Abbott Laboratories : Abbott and AbbVie Announce Investor Calls

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/14/2013 | 10:10am EST

Abbott Park, Illinois and North Chicago - Abbott (NYSE: ABT) will announce its fourth-quarter and full-year 2012 financial results on Wednesday, Jan. 23, 2013, before the market opens.

Abbott's quarterly and annual results will include contributions from the company's former research-based pharmaceutical business, which became AbbVie on Jan. 1, 2013. While these results will be captured in a single press release, both companies will host separate conference calls to discuss their respective business results and 2013 outlooks.

Abbott will host a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) on Jan. 23, 2013. It will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available after 11 a.m. Central time.

On Wednesday, Jan. 30, 2013, AbbVie will host a live webcast at 8 a.m. Central time (9 a.m. Eastern) accessible through AbbVie's Investor Relations website at www.abbvieinvestor.com. An archived edition of the call will be available after 11 a.m. Central time.

About Abbott

Abbott (NYSE: ABT) is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 70,000 people.

About AbbVie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. With its 125-year history, the company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries.www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

Abbott Contacts:
Media:
Scott Stoffel

(847) 936-9502
Financial:
Brian Yoor

(847) 937-6343
AbbVie Contacts:
Media:
Adelle Infante

(847) 938-8745
Financial:
Larry Peepo

(847) 935-6722
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ABBOTT LABORATORIES
01:38p ABBOTT LABORATORIES : Trademark Application for "FLEXIFLO" Filed by Abbott Labor..
01/18 ABBOTT : Announces European Launch of the Proclaim(TM) DRG Neurostimulation Syst..
01/17 ABBOTT LABORATORIES : New Data Confirms Abbott's Dorsal Root Ganglion Stimulatio..
01/16 ABBOTT LABORATORIES : Global Prebiotics Market 2017 - Abbott Laboratories, GNC, ..
01/12 ABBOTT LABORATORIES : Announces U.S. Launch and First Commercial Use of the New ..
01/12 ABBOTT : Announces U.S. Launch and First Commercial Use of the New EnSite(TM) Pr..
01/12 ABBOTT LABORATORIES : Trademark Application for "FRUITIFIED" Filed by Abbott Lab..
01/12 ABBOTT LABORATORIES : Trademark Application for "ZONEPERFECT INDULGENCE" Filed b..
01/12 ABBOTT LABORATORIES : ' Trademark Application for "KNOWLEDGE LADDERS" Filed
01/12 ABBOTT LABORATORIES : $30,000 Federal Contract Awarded to Abbott Laboratories
More news
Sector news : Pharmaceuticals - NEC
10:33a Davos CEOs 'go local' on supply chain in Trump era
05:15a GSK grabs Astra executive to replace pharma head
04:40aDJGLAXOSMITHKLINE : Global Pharmaceuticals President Abbas Hussain to Leave -- Upd..
02:48aDJBusiness Watch -- WSJ
02:28aDJGLAXOSMITHKLINE : Global Pharmaceuticals President Abbas Hussain to Leave
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
01/18 3 COMPANIES WITH RECENT DIVIDEND INC : Review Using Dividend Safety Model - Janu..
01/18 Valeant Gives Up Gains
01/18 Abbott launches new neurostimulation system in Europe
01/17 DGI FOR THE DIY : 2016 Portfolio Review
01/16 Bummed About Your Abbott Labs Dividend? Here's How To Boost It
Advertisement
Financials ($)
Sales 2016 20 898 M
EBIT 2016 4 077 M
Net income 2016 1 666 M
Debt 2016 4 126 M
Yield 2016 2,54%
P/E ratio 2016 22,83
P/E ratio 2017 17,36
EV / Sales 2016 3,56x
EV / Sales 2017 3,35x
Capitalization 70 360 M
More Financials
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | 4-Traders
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 46,7 $
Spread / Average Target 15%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Miles D. White Chairman & Chief Executive Officer
Brian B. Yoor Chief Financial Officer & Senior VP-Finance
Randel W. Woodgrift VP-Vascular, Manufacturing, Research & Development
Roxanne Schuh Austin Independent Director
Jim Farrell Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES6.12%70 360
JOHNSON & JOHNSON-0.44%312 045
ROCHE HOLDING LTD.1.29%203 230
PFIZER INC.-1.39%194 369
NOVARTIS AG-3.71%189 507
MERCK & CO., INC.3.91%168 654
More Results